Patents by Inventor Christopher Orme

Christopher Orme has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20060016331
    Abstract: A polyphosphazene having a glass transition temperature (“Tg”) of approximately ?20° C. or less. The polyphosphazene has at least one pendant group attached to a backbone of the polyphosphazene, wherein the pendant group has no halogen atoms. In addition, no aromatic groups are attached to an oxygen atom that is bound to a phosphorus atom of the backbone. The polyphosphazene may have a Tg ranging from approximately ?100° C. to approximately ?20° C. The polyphosphazene may be selected from the group consisting of poly[bis-3-phenyl-1-propoxy) phosphazene], poly[bis-(2-phenyl-1-ethoxy)phosphazene], poly[bis-(dodecanoxypolyethoxy)phosphazene], and poly[bis-(2-(2-(2-?-undecylenyloxyethoxy)ethoxy)ethoxy)phosphazene]. The polyphosphazene may be used in a separation membrane to selectively separate individual gases from a gas mixture, such as to separate polar gases from nonpolar gases in the gas mixture.
    Type: Application
    Filed: May 13, 2004
    Publication date: January 26, 2006
    Inventors: Frederick Stewart, Mason Harrup, Christopher Orme, Thomas Luther
  • Publication number: 20050272859
    Abstract: A PBI compound includes imidazole nitrogens at least a portion of which are substituted with an organic-inorganic hybrid moiety. At least 85% of the imidazole nitrogens may be substituted. The organic-inorganic hybrid moiety may be an organosilane moiety, for example, (R)Me2SiCH2—where R is selected from among methyl, phenyl, vinyl, and allyl. The PBI compound may exhibit similar thermal properties in comparison to the unsubstituted PBI. The PBI compound may exhibit a solubility in an organic solvent greater than the solubility of the unsubstituted PBI. The PBI compound may be included in separatory media. A substituted PBI synthesis method may include providing a parent PBI in a less than 5 wt % solvent solution. Substituting may occur at about room temperature and/or at about atmospheric pressure. Substituting may use at least 5 equivalents in relation to the imidazole nitrogens to be substituted or, preferably, about 15.
    Type: Application
    Filed: June 7, 2004
    Publication date: December 8, 2005
    Inventors: John Klaehn, Eric Peterson, Alan Wertsching, Christopher Orme, Thomas Luther, Michael Jones
  • Publication number: 20050272880
    Abstract: A PBI compound includes imidazole nitrogens at least a portion of which are substituted with a moiety containing a carbonyl group, the substituted imidazole nitrogens being bonded to carbon of the carbonyl group. At least 85% of the nitrogens may be substituted. The carbonyl-containing moiety may include RCO—, where R is alkoxy or haloalkyl. The PBI compound may exhibit a first temperature marking an onset of weight loss corresponding to reversion of the substituted PBI that is less than a second temperature marking an onset of decomposition of an otherwise identical PBI compound without the substituted moiety. The PBI compound may be included in separatory media. A substituted PBI synthesis method may include providing a parent PBI in a less than 5 wt % solvent solution. Substituting may use more than 5 equivalents in relation to the imidazole nitrogens to be substituted.
    Type: Application
    Filed: October 19, 2004
    Publication date: December 8, 2005
    Inventors: John Klaehn, Eric Peterson, Christopher Orme, Michael Jones, Alan Wertsching, Thomas Luther, Tammy Trowbridge